---

Evaluation of role of serum prolactin & ki-67 in different stages of breast cancer

---

Original Article

Author Details : Sandeep Kumar, Neha Mala Krishna, Pallavi Sagar*, Manish Kumar, J R Keshari

Volume : 10, Issue : 1, Year : 2023

Article Page : 55-59

https://doi.org/10.18231/j.ijcbr.2023.008

Suggest article by email

Get Permission

---

Abstract

Breast cancer is the most frequent cancer among women. Prolactin (PRL) is a hormone secreted from anterior pituitary gland which stimulates cell proliferation, survival of cancer cells, its migration, invasion and angiogenesis. Breast cancer is strongly associated with raised plasma Prolactin level (PRL). The Prolactin behaves like Growth Hormone and its actions by the growth-promoting JAK/STAT pathway suggests its tumor-promoting effects.Ki-67 a Nuclear Protein is highest in Luminal B, Ki67 are not related to age but is correlated with tumor size. Fraction of Ki-67 positive tumor cells correlates with the clinical course of cancer cells. Hence, Ki- 67 can be an effective target in cancer therapy. Ki-67% and Serum Prolactin level may be considered a valuable biomarker in breast cancer patients and be used in treatment, follow-up and Prognosis.
 

Keywords: Breast cancer, Prolactin, Ki­67.

How to cite : Kumar S, Krishna N M, Sagar P, Kumar M, Keshari J R, Evaluation of role of serum prolactin & ki-67 in different stages of breast cancer. Int J Clin Biochem Res 2023;10(1):55-59

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.